Skip to content
Friday, November 13, 2026
Explore the latest trends in tech and business with expert …

Users Stopping Slimming Injections Put On Pounds at a Quadrupled Rate Than Those on Conventional Diets

Image of pharmaceutical syringe and scale
Obesity treatment involves long-term strategies.

New research suggests that patients who stop using popular weight-loss injections like Mounjaro or Wegovy may regain lost weight far faster than those who halt conventional lifestyle plans.

Findings released in a major medical journal demonstrates that while overweight individuals frequently drop about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Users using such treatments need to be cognizant of the potential of quick rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to pre-treatment mass in about 18 months.

Comparing Treatments

The analysis, which reviewed dozens of trials involving over 9,000 of participants, compared the outcomes of these new drugs with older methods.

Scientists emphasize that people who shed pounds through diet and exercise generally experience a less rapid weight regain—perhaps 100 grams monthly—once they finish.

Explaining the Fast Rebound

Experts suggest the way of the injections accounts for the heightened regain.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement means hunger is uncontrolled, making excessive eating far more likely."

A Lifelong Issue?

Medical guidelines advise the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians argue that, considering the high risk of relapse, the therapy is often ongoing.

This view is reinforced by drug manufacturers, who say that the findings "emphasize the persistent character of obesity," akin to managing diseases like hypertension.

Patient Experiences

Users who have stopped the medication report a sudden return of cravings.

"It felt as if a switch that goes on and you're instantly ravenous," recalled an individual.

The struggle is worsened if users have not established permanent dietary or behavioural modifications during therapy.

Widespread Interest

Recent estimates show that millions of adults in the UK have used these injections in the last 12 months, with desire being substantial.

  • Use is more common among women compared to males.
  • The 40s and 50s age group shows the greatest level of interest.
  • A large proportion access the drugs through private prescriptions rather than the NHS.

Ultimately, experts emphasize that while the jabs are effective agents for weight loss, they are not a permanent solution and maintained weight loss relies on combined behavioural support.

Written by

Kurt Leon

A tech enthusiast and indie game developer passionate about sharing knowledge and fostering creativity in digital spaces.

KMB Blog

Type to search articles.